'Excellent safety' of 2 indigenous COVID candidate vaccines revealed during Phase-I trials: Minister

Serum Institute of India (SII) and ICMR have partnered for clinical development of two global vaccine candidates.
Source: The Economic Times - Category: Consumer Health News Source Type: news